Ryoncil ® was approved in December 2024 by the United States Food and Drug Administration (FDA) for steroid-refractory acute ...

BCDA], a developer of cellular therapies for cardiovascular diseases with a current market capitalization of $12 million, has announced the completion of enrollment and dosing for the low-dose cohort ...

BioCardia (BCDA) announced completion of enrollment and dosing in the low dose cohort in its CardiALLO Allogeneic Mesenchymal Cell Therapy ...

A study found that injecting mesenchymal stem cells into periocular tissue effectively reduces eye inflammation without ...

当然say “no”，目前人们已经开始采取了一系列综合的方法干预炎症性衰老，包括 饮食、运动、生活方式的改变以及必要时的药物治疗。通过这些措施，可以有效地降低身体的炎症水平，从而延缓衰老过程和减少与衰老相关的疾病风险。随着再生医学的蓬勃发展， ...

This application note demonstrates how combining live-cell analysis with high-throughput screening cytometry enables ...

You may be familiar with Guerlain's Abeille Royale line, but the new Water Oil Serum has been majorly revamped. The French ...

The heart drug digoxin could potentially be combined with existing cancer therapies to prevent the spread of tumors, an early ...

Dr. Shimmura explained that this therapy offers two major benefits: it reduces inflammation and promotes healing at the same ...

This important study focused on characterizing clonally derived MSC populations from the synovium of normal and osteoarthritis (OA) patients, demonstrating their potential to regenerate cartilage in ...

Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the ...